Cathepsin D and dynamic magnetic resonance imaging gadolinium enhancement in malignant and benign breast lesions

Clinical Cancer Research

Volumn 3, Issue 4, 1997, Pages 559-563

  Stomper, Paul C ^a   Winston, Janet S ^a   Herman, Steven ^a   Klippenstein, Donald L ^a   Blumenson, Leslie E ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN D; GADOLINIUM PENTETATE;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST LESION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

BIOPSY; BREAST; BREAST DISEASES; BREAST NEOPLASMS; CATHEPSIN D; CONTRAST MEDIA; FEMALE; GADOLINIUM; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; NEOPLASM INVASIVENESS;

EID: 0030917535     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Itoh, Y., Kobayashi, S., Iwase, H., Yamashita, H., Kuzushima, T., Iwata, H., Yamashita, T., Naitoh, A., Itoh, K., and Masaoka, A. Clinical significance of cathepsin-D assay in breast cancer tissues. J. Surg. Oncol., 60: 221-226, 1995.
2. Schwartz, M. K. Tissue cathepsins as tumor markers (Review). Clin. Chirn. Acta, 237: 67-78, 1995.
3. Shaheen, R. M., Miseljic, S., Wiehle, R. D., and Wittliff, J. L. Relation between cathepsin-D expression and other prognostic factors in breast carcinoma. Clin. Chem., 41: 1585-1591, 1995.
4. O'Donoghue, A. E., Poller, D. N., Bell, J. A., Galea, M. H., Elston, C. W., Blarney, R. W., and Ellis, I. O. Cathepsin-D in primary breast carcinoma: adverse prognosis is associated with expression of cathepsin-D in stromal cells. Breast Cancer Res. Treat., 33: 137-145, 1995.
5. Rochefort, H., Capony, F., and Garcia, M. A protease involved in breast cancer metastasis. Cancer Metastasis Rev., 9: 321-331, 1990.
6. Kute, T. E., Shao, Z. M., Sugg, N. K., Long, R. T., Russell, G. B., and Case, L. D. Cathepsin D as a prognostic indicator for node-negative breast cancer patients using both immunoassays and enzymatic assays. Cancer Res., 52: 5198-5203, 1992.
7. Ravdin, P. M. Evaluation of cathepsin D as a prognostic factor in breast cancer. Breast Cancer Res. Treat., 24: 219-226, 1993.
8. Kandalaft, P. L., Chang, K. L., Ahn, C. W., Traweek, S. T., Mehta, P., and Battifora, H. Prognostic significance of immunohistochemical analysis of cathepsin D in low-stage breast cancer. Cancer (Phila.), 71: 2756-2763, 1993.
9. Domagala, W., Striker, G., Szadowska, A., Dukowicz, A., Weber, K., and Osborn, M. Cathepsin D in invasive ductal NOS breast carcinoma as defined by immunohistochemistry: no correlation with survival at 5 years. Am. J. Pathol., 141: 1003-1012, 1992.
10. Duffy, M. J., Brouillet, J. P., Reilly, D., McDermott, E., O'Higgins, N., Fennelly, J. J., Maudelonde, T., and Rochefort, H. Cathepsin D concentration in breast cancer cytosols: correlation with biochemical, histological, and clinical findings. Clin. Chem., 37: 101-104, 1991.
11. Granata, G., Coradini, D., Cappeletti, V., and Di Fronzo, G. Prognostic relevance of cathepsin D versus oestrogen receptors in node negative breast cancers. Eur. J. Cancer, 27: 970-972, 1991.
12. Rochefort, H. Response to P. M. Ravdin (BCRT 24:219-226, 1993), Evaluation of cathepsin D as a prognostic factor in breast cancer. Breast Cancer Res. Treat., 26: 107-109, 1993.
13. Weinreb, J. C., and Newstead, G. MR imaging of the breast. Radiology, 796: 593-610, 1995.
14. Harms, S. E., Flamig, D. P., Hesley, K. L., Meiches, M. D., Jensen, R. A., Evans, W. P., Savino, D. A., and Wells, R. V. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology, 187: 493-501, 1993.
15. Heywang-Koebrunner, S. H. Diagnosis of breast cancer with MR: review after 1250 patient examinations. Electromedica (Engl. Ed.), 61: 43-52, 1993.
16. Stack, J. P., Redmond, O. M., Codd, M. B., Dervan, P. A., and Ennis, J. T. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology, 174: 491-494, 1990.
17. Rubens, D., Totterman, S., Chacko, A. K., Kothari, K., Logan-Young, W., Szumowski, J., Simon, J. and Zachariah, Gadopentetate dimeglumine-enhanced chemical-shift MR imaging of the breast. Am. J. Roentgenol., 157: 267-270, 1991.
18. Orel, S., Schnall, M. D., Powell, C. M., Hochman, M. G., Solin, L. J. Fowble, B. L., Torosian, M. H., and Rosato, E. F. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology, 196: 115-122, 1995.
19. Flickinger, F. W., Allison, J. D., Sherry, R. M., and Wright, J. C. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI. Magn. Reson. Imaging, 11: 617-620, 1993.
20. Orel, S., Schnall, M. D., LiVolsi, V. A., and Troupin, R. H. Suspicious breast lesions: MR imaging with radiologic-pathologic correlations. Radiology, 190: 485-493, 1994.
21. Fobben, E. S., Rubin, C. Z., Kalisher, L., Dembner, A. G., Seltzer, M. H., and Santoro, E. J. Breast MR imaging with commercially available techniques: radiologic-pathologic correlation. Radiology, 196: 143-152, 1995.
22. Stomper, P. C., Herman, S., Klippenstein, D. L., Winston, J. S., Edge, S. B., Arredondo, M. A., Mazurchuk, R. V., and Blumenson, L. E. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology, 197: 387-395, 1995.
23. Stomper, P. C., Herman, S., Klippenstein, D. L., Winston, J. S., Budnick, R. M., and Stewart, C. C. Invasive breast carcinoma: analysis of dynamic magnetic resonance imaging enhancement features and cell proliferative activity determined by DNA S-phase percentage. Cancer (Phila.), 77: 1844-1849, 1996.
24. Gilles, R., Zafrani, B., Guinebretière, J. M., Meunier, M., Lucidarme, O., Tardivon, A. A., Rochard, F., Vanel, D., Neuenshwander, S., and Arriagada, R. Ductal carcinoma in situ: MR imaging-histopathologic correlation. Radiology, 796: 415-419, 1995.
25. Hulka, C. A., Smith, B. L., Sgroi, D. C., Tan, L., Edmister, W. B., Semple, J. P., Campbell, T., Kopans, D. B., Brady, T. J., and Weisskoff, R. M. Benign and malignant breast lesions: differentiation with echoplanar MR imaging. Radiology, 197: 33-38, 1995.
26. Fleiss, J. L. Statistical Methods for Rates and Proportions, Ed. 2, pp 20-27. New York: John Wiley & Sons, Inc., 1981.
27. Chadha, M., Chabon, A., Friedmann, P., and Vikram, B. Predictors of axillary lymph node metastases in patients with T1 breast cancer: a multivariate analysis. Cancer (Phila.), 73: 350-353, 1994.
28. Ravdin, P. M., DeLaurentiis, M., Vendely, T., and Clark, G. M. Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators. J. Natl. Cancer Inst., 86: 1771-1775, 1994.
29. Cady, B. The need to reexamine axillary lymph node dissection in invasive breast cancer. Cancer (Phila.), 73: 505-508, 1994.
30. Jain, R. K. Barriers to drug delivery in solid tumors. Sci. Am., 271-58-65, 1994.
31. Jain, R. K. 1995 Whitaker Lecture: delivery of molecules, particles, and cells to solid tumors. Ann. Biomed. Eng., 24: 457-473, 1996.
32. van Dijke, C. F., Brasch, R. C., Roberts, T. P. L., Weidner, N., Mathur, A., Shames, D. M., Mann, J. S., Demsar, F., Lang, P., and Schwickert, H. C. Mammary carcinoma model: correlation of macromolecular contrast enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology, 198: 813-818, 1996.
33. Schwickert, H. C., Stiskal, M., Roberts, T. P. L., van Dijke, C. F., Mann, J., Muhler, A., Shames, D. M., Demsar, F., Disston, A., and Brasch, R. C. Contrast-enhanced MRI assessment of tumor capillary permeability: the effect of pre-irradiation on the tumor delivery of chemotherapy. Radiology, 198: 893-898, 1996.
34. Cohen, F. M., Kuwatsuru, R., Shames, D. M., Neuder, M., Mann, J. S., Vexler, V., Rosenau, W., and Brasch, R. C. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after x-irradiation. Invest. Radiol., 29: 970-977, 1994.